Invention Application
- Patent Title: ALLOGENEIC TUMOR CELL VACCINATION
- Patent Title (中): ALLOGENEIC肿瘤细胞疫苗
-
Application No.: US15051205Application Date: 2016-02-23
-
Publication No.: US20160175416A1Publication Date: 2016-06-23
- Inventor: Tamar PERETZ , Michal LOTEM , Arthur MACHLENKIN , Shoshana FRANKENBURG , Inna BEN DAVID , Anna KUZNETZ , Yael GELFAND , Galit EISENBERG , Merav DARASH YAHANA
- Applicant: Hadasit Medical Research Services and Development Ltd.
- Applicant Address: IL Jerusalem
- Assignee: Hadasit Medical Research Services and Development Ltd.
- Current Assignee: Hadasit Medical Research Services and Development Ltd.
- Current Assignee Address: IL Jerusalem
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C12N5/09
Abstract:
The present invention relates to cancer immunotherapy, specifically to allogeneic tumor cell vaccines. According to some embodiments, the invention provides novel cell lines useful as therapeutic cell vaccine compositions. The invention further provides advantageous screening methods and means for identifying patients amenable for treatment with partially Human Leukocyte Antigen (HLA) matched allogeneic cell vaccines. Therapeutic compositions and methods for use in proliferative disorders are further provided.
Public/Granted literature
- US10064927B2 Allogeneic tumor cell vaccination Public/Granted day:2018-09-04
Information query
